Information provided by: ITC-Diligence International, experts in Foreign Trade Zone operations.
Southern Nevada is quietly building a biotech ecosystem that’s catching national attention. With growing momentum in funding, research facilities, and bold city initiatives, Southern Nevada is laying the foundation for impactful growth in life sciences.
Breaking the Sample Habit
Recent coverage framed Southern Nevada as a “surprise biotech hub,” noting a bioscience sector employing more than 9,400 professionals and posting a 22% growth from 2018 to 2021, a pace well above national averages.
UNLV’s Desert Forge Ventures launched this spring, offering $100,000–$1 million in funding for deep-tech startups including biotech innovators. The fund provides local capital instead of forcing companies to leave the Valley for the Bay Area.
Meanwhile, Fixx Pharmaceuticals, a new gene-editing company based in Southern Nevada, is developing CRISPR-based therapies for hemophilia.
Building the Biotech Infrastructure
A $10 million BioHealth Innovation Challenge is underway, offering funding for a biosciences incubator lab in the expanding Southern Nevada Medical District.
UNLV is investing sharply in biotech infrastructure too with a 122-acre Research & Technology Park that includes wet-lab space and the Blackfire Innovation accelerator, in partnership with Caesars.
Organizations such as NevBio are strengthening regional biotech connections through events, member networks, and academic-industry collaborations.
Why Vegas Makes Sense for Biotech
- Natural climate features help reduce humidity-control costs particularly valuable for sensitive biological substances.
- The cost of living remains significantly lower than coastal hubs like San Francisco offering affordability without sacrificing talent or innovation.
- Students and researchers at UNLV are gaining momentum. The university’s research awards have exceeded $134 million annually, with growing investment in biological and clinical research.
A Trade Advantage for Biotech Manufacturers
For biotech companies that rely on importing lab equipment, medical devices, or specialized components, Foreign Trade Zone (FTZ) #89 (managed by LVGEA), offers a key operational advantage. Located in Southern Nevada, this federal program allows qualifying businesses to defer or reduce import duties, speed up customs processes, and improve cash flow tied to international shipments.
Furthermore, these cost-saving benefits help life sciences companies scale more efficiently, especially those involved in lab infrastructure, device assembly, diagnostics, or biomanufacturing.
Whether you’re sourcing globally or preparing to export new biotech products, FTZ #89 can help optimize the path from R&D to commercialization.
LVGEA: Your Connector to Biotech Growth
- LVGEA connects growing companies to incentives, such as redevelopment zones within the Medical District offering support for lab construction.
- We help startups navigate funding pathways that include Desert Forge and state-backed venture opportunities.
- We facilitate introductions to UNLV, Blackfire Innovation, Roseman University, and NevBio all in an effort to support biotech founders seeking lab-ready infrastructure and a workforce pipeline.
A Test Tube Ready to Grow
Southern Nevada may be viewed as the entertainment mecca, but now more than ever it’s preparing for the next chapter: biotech. With new capital, infrastructure, and academic partnerships rising fast, Southern Nevada is poised to be a launchpad for life sciences innovation.
Want to explore how your biotech company can scale here? Connect with LVGEA today.
